Fundamentals for Immupharma ( imm )
Current Price: 0.02
Market Cap: 9.39m
Price / Net Assets: 3.73
Internal Rate of Return: 0%
PE10 Ratio: -1.67
Dividend Yield: 0%
Currency: £ GBP
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (m) | £0m | £0.12m | £0.13m | £0.08m | £0.08m | £0.15m | £0.16m | £0.08m | £0.18m | £0m | £0m |
| Revenue Growth | -100.00% | -7.69% | 62.50% | 0.00% | -46.67% | -6.25% | 100.00% | -55.56% | - | - | -6% |
| Profit / Loss | £-3.81m | £-8.17m | £-6.86m | £-6.12m | £-7.21m | £-6.22m | £-5.32m | £-3.9m | £-2.87m | £-3.69m | £-5m |
| Profit Increase/Decrease | -53.37% | 19.10% | 12.09% | -15.12% | 15.92% | 16.92% | 36.41% | 35.89% | -22.22% | - | 5% |
| Profit / Sales Ratio | - | - | - | - | - | - | - | - | - | - | 0% |
| Earnings per Share | £-0.01 | £-0.03 | £0.03 | £-0.04 | £-0.05 | £-0.05 | £-0.05 | £-0.04 | £-0.03 | £-0.05 | £-0.03 |
| Total Debt | £1.45m | £1.59m | £1.27m | £0.53m | £1.04m | £1.45m | £1.16m | £1.52m | £1.36m | £1.81m | £1.32m |
| Net Assets | £2.52m | £4.41m | £9.65m | £5.27m | £7.62m | £3.57m | £5.55m | £1.69m | £5.71m | £5.40m | £5.14m |
| Debt / Asset Ratio | 36.52% | 26.50% | 11.63% | 9.14% | 12.01% | 28.88% | 17.29% | 47.35% | 19.24% | 25.10% | 25.10% |
| Dividend per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.00% |
| Dividend Cover | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0.00x |